News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Tsumura & Co.'s "Kampo" Ethical Drug Receives FDA Approval Of IND


10/19/2005 5:09:58 PM

Japanese major Chinese herbal medicine (kampo) distributor Tsumura (TSE: 4540) announced February 6 that it has received an IND (investigational new drug) approval for its drug "Keishi-bukuryu-gan," extract granules for ethical use, from the US Food and Drug Administration.

Read at JCN Newswire

comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES